A detailed history of Russell Investments Group, Ltd. transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 38,205 shares of CTKB stock, worth $247,950. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,205
Previous 8,360 357.0%
Holding current value
$247,950
Previous $46,000 358.7%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.73 - $6.73 $141,166 - $200,856
29,845 Added 357.0%
38,205 $211,000
Q2 2024

Aug 08, 2024

BUY
$5.3 - $6.91 $43,290 - $56,440
8,168 Added 4254.17%
8,360 $46,000
Q1 2024

May 08, 2024

BUY
$6.29 - $9.15 $446 - $649
71 Added 58.68%
192 $1,000
Q4 2023

Feb 05, 2024

BUY
$4.1 - $9.51 $496 - $1,150
121 New
121 $1,000

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $874M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.